Status Topic selection
Technology type Medicine
Decision Awaiting decision
ID number 9716

Project Team

Project lead Abbie Stephens

Email enquiries


Key events during the development of the guidance:

Date Update
11 September 2023 Topic selection. Dear stakeholders, As you will be aware, the Department for Health & Social Care has asked NICE to carry out a Single Technology Appraisal of TSID9716 - Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy. For information, the company are not planning to submit to NICE at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme.
11 August 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on how we select topics for development, please see our page about topic selection